CN105708885A - Drug used for treating gout - Google Patents

Drug used for treating gout Download PDF

Info

Publication number
CN105708885A
CN105708885A CN201410717658.4A CN201410717658A CN105708885A CN 105708885 A CN105708885 A CN 105708885A CN 201410717658 A CN201410717658 A CN 201410717658A CN 105708885 A CN105708885 A CN 105708885A
Authority
CN
China
Prior art keywords
radix achyranthis
achyranthis bidentatae
cortex eucommiae
shark cartilage
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410717658.4A
Other languages
Chinese (zh)
Inventor
王群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410717658.4A priority Critical patent/CN105708885A/en
Publication of CN105708885A publication Critical patent/CN105708885A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a drug used for treating gout. The drug comprises, by weight, 60g of shark cartilage, 90g of cortex eucommiae, and 90g of radix achyranthis bidentatae. A preparation method comprises following steps: 60g of shark cartilage is baked and grinded, is divided into 12 parts, and is packaged; one part of the processed shark cartilage is taken in two times each day; cortex eucommiae and radix achyranthis bidentatae are fried with salt water, and are decocted with water so as to obtain a decoction, and the obtained decoction is divided into 24 parts. The processed shark cartilage is taken together with the decoction. Cortex eucommiae is sweet in taste, slightly pungent, and warm in nature, belongs to liver and kidney channel, is capable of harmonizing gas and reducing moisture, nourishing liver and kidney, strengthening bones and muscles, and preventing miscarriage, and is mainly used for treating waist and knee pain, erectile dysfunction, spermatorrhea, frequent micturition, long lasting urinating, yang-hyperactivity and arthralgia spasm pain, rheumatic arthralgia, pruritus vulvae, threatened abortion, miscarriage and abortion. Radix achyranthis bidentatae is sweet, bitter, and sour in taste, and is neutral in nature; raw radix achyranthis bidentatae is capable of dispersing blood stasis, and relieving carbuncle swollen, and is mainly used for treating gonorrhea, hematuria, amenorrhea, abdominal mass, dystocia, placenta retension, postpartum blood stasis and stomachache, pharyngitis, carbuncle swollen, injuries from falls, fractures, contusions and strains; and processed radix achyranthis bidentatae is capable of nourishing liver and kidney, and strengthening bones and muscles, and is mainly used for treating waist knee bone pain, arms and legs contracture, and atrophy and flaccidity.

Description

A kind of medicine treating gout
Technical field
The present invention relates to medicine making field, specifically a kind of Traditional chinese medicine medicament formula treating gout.
Background technology
Gout on modern clinic, many application Western medicine class medicines, these medicine side effect are big, and Time of Administration is long, mostly has additive, and after drug withdrawal, relapse rate is high, and can not effect a radical cure.
Summary of the invention
The present invention solves existing Drug therapy neurasthenia and the big problem of insomnia's side effect, invent a kind of compound method utilizing treatment by Chinese herbs gout.
The technical scheme is that, a kind of medicine treating gout, including: shark first, the Cortex Eucommiae, Radix Achyranthis Bidentatae
Components by weight: shark first 60 grams, the Cortex Eucommiae 90 grams, Radix Achyranthis Bidentatae 90 grams
Making is taken: shark first 60 grams, the Cortex Eucommiae 90 grams, Radix Achyranthis Bidentatae 90 grams, and shark first is dried and ground bread and become 12 bags, and every day 1 wraps, and takes day twice, after Cortex Eucommiae Radix Achyranthis Bidentatae is fried with saline, decocts moisture 24 times, takes first face.
Cortex Eucommiae sweet in the mouth, micro-pungent, warm in nature.Return liver, kidney channel.Gas and profit drop.Invigorating the liver and kidney, bone and muscle strengthening, antiabortive.Curing mainly soreness of waist and knee joint, sexual impotence, seminal emission, frequent micturition, dribbling urination, yang hyperactivity dizziness, rheumatic arthralgia, uncontrolled urination is itched, frequent fetal movement, leaks tire abortion.Radix Achyranthis Bidentatae nature and flavor sweetness and bitterness is sour, flat, and its effect is: life dissipating blood stasis blood, subduing inflammation, cures mainly gonorrhea, hematuria, amenorrhea, lump in the abdomen, difficult labour, retention of placenta, and postnatal blood stasis is suffered from abdominal pain, sore throat, carbuncle, traumatic injury;Ripe invigorating the liver and kidney, bone and muscle strengthening, cure mainly the diseases such as waist kneecap pain, spasm of the limbs, flaccidity syndrome and arthralgia syndrome.
Technique effect
The solution have the advantages that, adopt above-mentioned technical scheme, it is possible to achieve a kind of medicine treating gout.This medicine is without any side effects, and without drug dependence, formula is simple, taking convenience, and cost is low, good effect, and cure rate is high.Through clinical practice for many years, effective percentage 100%, cure rate more than 95%, being obviously improved for one course for the treatment of (10 days) symptom of general patient with gout, usual 2-3 the course for the treatment of can cure, for patient with severe symptoms usual 2 the course for the treatment of symptom be obviously improved, and recurrence probability extremely low.
Detailed description of the invention
Embodiment 1
Shark first 60 grams, the Cortex Eucommiae 90 grams, Radix Achyranthis Bidentatae 90 grams, shark first is dried and is ground bread and become 12 bags, and every day 1 wraps, and takes day twice, after Cortex Eucommiae Radix Achyranthis Bidentatae is fried with saline, decocts moisture 24 times, takes first face.

Claims (1)

1. treat a medicine for gout, it is characterized in that including: shark first, the Cortex Eucommiae, Radix Achyranthis Bidentatae;Components by weight: shark first 60 grams, the Cortex Eucommiae 90 grams, Radix Achyranthis Bidentatae 90 grams.
CN201410717658.4A 2014-12-03 2014-12-03 Drug used for treating gout Pending CN105708885A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410717658.4A CN105708885A (en) 2014-12-03 2014-12-03 Drug used for treating gout

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410717658.4A CN105708885A (en) 2014-12-03 2014-12-03 Drug used for treating gout

Publications (1)

Publication Number Publication Date
CN105708885A true CN105708885A (en) 2016-06-29

Family

ID=56146183

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410717658.4A Pending CN105708885A (en) 2014-12-03 2014-12-03 Drug used for treating gout

Country Status (1)

Country Link
CN (1) CN105708885A (en)

Similar Documents

Publication Publication Date Title
CN102988657B (en) Plaster for treating fracture and traumatic injury and preparation method of plaster
CN104491776A (en) Tradtional Chinese medicine preparation for treating chronic limb arteriosclerosis obliterans and preparation method thereof
CN105708885A (en) Drug used for treating gout
CN102048965A (en) Medicinal knee belt for treating rheumatalgia
CN106109572A (en) One treats osteoporotic Chinese medicine composition and preparation method thereof
CN105663210A (en) Medicine for treating hyperostosis
CN104069457A (en) Traditional Chinese medicine for treating lumbar muscle strain
CN107261080A (en) It is a kind of to treat liniment of chronic bronchial asthma and preparation method thereof
CN107582964A (en) A kind of pill medicine and preparation method that can effectively treat rheumatoid arthritis
CN106581129A (en) Traditional Chinese medicine drug formula for treating gout
CN104173965B (en) Medicated wine for curing traumatic injury and preparation method thereof
CN105663211A (en) Medicine for treating hyperosteogeny
CN106539849A (en) A kind of medicine for treating osteoproliferation
CN106420892A (en) Traditional Chinese medicine formula for treating gout
CN107375715A (en) A kind of Chinese medicine composition for treating moderate Atherosclerotic thrombotic cerebral infarction
CN106551983A (en) A kind of medicine for treating gout
CN106539850A (en) A kind of medicine for treating gout
CN105663209A (en) Medicine for treating hyperosteogeny
CN107737295A (en) Treat medicine of neck-shoulder pain, lumbago and leg pain and preparation method thereof
CN106109695A (en) One can effectively treat osteoporotic pill medicine and preparation method thereof
CN109106745A (en) A kind of drug for treating gout
CN106138415A (en) A kind of Chinese medicine composition of the femur head necrosis caused for a variety of causes
CN106728525A (en) A kind of Chinese medicine composition for the treatment of of arthritis and preparation method thereof
CN105233047A (en) Nursing plaster for treating meniscus injury of knee joint
CN103721225B (en) A kind of medicine for the treatment of piriformis syndrome and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160629